Chemoinformaics analysis of BUTYL OCTADECYL SULFITE
| Molecular Weight | 390.674 | nRot | 22 |
| Heavy Atom Molecular Weight | 344.306 | nRig | 1 |
| Exact Molecular Weight | 390.317 | nRing | 0 |
| Solubility: LogS | 0.111 | nHRing | 0 |
| Solubility: LogP | 0.945 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 72.7185 |
| nHD | 0 | BPOL | 54.1775 |
| QED | 0.543 |
| Synth | 1.744 |
| Natural Product Likeliness | 0.484 |
| NR-PPAR-gamma | 0.173 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.019 |
| HIA | 0.011 |
| CACO-2 | -4.807 |
| MDCK | 0.000260239 |
| BBB | 0.887 |
| PPB | 0.431131 |
| VDSS | 0.245 |
| FU | 0.630338 |
| CYP1A2-inh | 0.029 |
| CYP1A2-sub | 0.23 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.136 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.93 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.24 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.045 |
| CL | 7.386 |
| T12 | 0.832 |
| hERG | 0.009 |
| Ames | 0.011 |
| ROA | 0.154 |
| SkinSen | 0.213 |
| Carcinogencity | 0.11 |
| EI | 0.993 |
| Respiratory | 0.046 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.682683 |